Sinopharm Group (OTCMKTS:SHTDY) Trading 0.1% Higher – Still a Buy?
by Renee Jackson · The Cerbat GemSinopharm Group Co. Ltd. (OTCMKTS:SHTDY – Get Free Report) shares were up 0.1% during trading on Friday . The company traded as high as $12.92 and last traded at $12.8450. Approximately 57,425 shares traded hands during mid-day trading, an increase of 8% from the average daily volume of 53,400 shares. The stock had previously closed at $12.8360.
Sinopharm Group Stock Performance
The company has a 50 day simple moving average of $13.41 and a 200-day simple moving average of $12.86.
Sinopharm Group Company Profile
Sinopharm Group Co, Ltd. (OTCMKTS:SHTDY) is one of China’s largest integrated healthcare companies and an indirect subsidiary of the state-owned China National Pharmaceutical Group Co, Ltd. The company operates through two primary segments—pharmaceutical distribution and retail pharmacy—offering comprehensive supply chain solutions that span procurement, storage, transportation and sales of medical products. With a broad portfolio that includes prescription drugs, over-the counter medicines, medical devices and consumables, Sinopharm serves hospitals, clinics, retail pharmacies and other healthcare institutions across mainland China.
In its distribution business, Sinopharm leverages an extensive logistics network, comprising hundreds of distribution centers and thousands of delivery vehicles, to ensure timely delivery of pharmaceuticals under stringent temperature-controlled conditions.